AstraZeneca Korea will challenge to treat gastric adenocarcinoma with the combination therapy of bispecific antibody candidate substances.The Ministry of Food and Drug Safety approved on Thursday phase 2 clinical trial on the efficacy and safety of the combo therapy of MED15752 and AZD2936 on patien
Coreline Soft, a medical artificial intelligence (AI) company, said on Friday that it obtained medical device certification (pre-market authorization) from the Singapore Health Sciences Authority (HSA) for nine of its AI-based solutions on Saturday.The certificate includes AVIEW products for analysi
President Yoon Suk-yeol reportedly has decided to name Jee Young-mee, CEO of Institut Pasteur Korea, as the new comissioner of the Korea Disease Control and Prevention Agency (KDCA)."We have gone through personnel verification for Jee from two weeks ago and selected Jee as our final candidate," a pr
RIGHT Foundation held a briefing session on Thursday to explain the eligibility criteria for two ongoing project grants and share about 2023 co-funding projects.Accordingly, the Product Development Award (PDA) is targeted at companies or research institutions developing vaccines, treatments, and dia
A group of researchers led by Ajou University Medical Center (AUMC) and the University of Pittsburgh School of Medicine said it was possible to predict dementia in advance by looking at the brain age.Samsung Medical Center, Inha University Hospital, Pusan National University Hospital, and Chonnam Na
After President Yoon Suk-yeol declared to throw away ‘Moon Care,” civic groups hit back, saying it was an attempt to reduce health insurance coverage.“If President Yoon takes the lead in attacking health insurance, his government will not remain safe,” the Campaign Headquarters for Preventing Medica
Former President Moon Jae-in’s policy to enhance health insurance coverage, called Moon Jae-in care or “Moon Care,” has become a bone of contention in the political community.The controversy surfaced after the incumbent chief executive, Yoon Suk-yeol, declared to repeal his predecessor’s policy, des
Amid the Covid-19 winter resurgence trend, mathematicians predicted an increase in daily Covid-19 cases for the next two weeks. Some even forecast that the number could exceed 100,000.A team at the National Institute for Mathematical Science (NIMS) concluded that Covid-19 cases will surpass 100,000
With the increasing incidence of shingles in Korea due to the rapid population aging, GSK Korea said it would release Shingrix, a new vaccine that prevents shingles with over 90 percent efficacy. The company held a press conference Thursday to celebrate the upcoming launch of the new vaccine.Shingle
GC Corp. said Thursday that its patch-type influenza vaccine MIMIX-Flu, a co-development item with U.S. Vaxess Technologies, proved safety and immunogenicity in a phase 1 trial.MIMIX-Flu is a device that combines GC's influenza vaccine antigen with Vaxess's patch-based subcutaneous drug delivery tec
According to the 2019 national cancer registration statistics by the Ministry of Health and Welfare and Korea Central Cancer Registry, the annual number of newly diagnosed breast cancer patients exceeded 20,000 in 2016. As of 2019, breast cancer ranked first among cancer in women in Korea.Fortunatel
One of the most popular medical departments among interns is orthopedics.The department reaffirmed its popularity in the application chart for the first half of 2023. No teaching hospitals recruiting resident orthopedists experienced a shortage of applicants below their quota.However, university hos
Lunit said on Thursday that a study published in the January 2023 issue of The Lancet Regional Health–Americas, demonstrated the effectiveness of Lunit’s INSIGHT CXR as a triage tool for tuberculosis (TB) screening in prisons.Globally, prisons are high-risk settings for TB. In South America, TB case
LG Chem said Thursday that it had signed an agreement to transfer the exclusive right to develop and commercialize its new gout drug, Tigulixostat, in China, to Innovent Biologics, a Chinese pharmaceutical company.LG Chem has secured an upfront payment of $10 million, and can receive up to $85.5 mil
Korea’s new Covid-19 cases remained above 80,000 for the second straight day. However, despite the rise of the BN.1 mutations, officials said its spread would not be as quick as the BA.5 variant.Even amid the resurge of new virus cases, the Korea Disease Control and Prevention Agency (KDCA) said it
The Health Insurance Review and Assessment Service (HIRA) said it would operate a system to manage “super-expensive” drugs, such as Kymriah and Zolgensma, including their course of medication.The state-run agency said Wednesday that it would run the system to “manage expensive drugs” to enhance the
GC Wellbeing has signed a technology transfer and joint development agreement for GCWB204, its cancer cachexia treatment candidate, with MThera Pharma.In a European phase 2a clinical trial last year, GC Wellbeing confirmed the potential of GCWB204 as a treatment for cancer cachexia in multiple evalu
As the calls grow for fostering a professional workforce in the biopharmaceutical industry, Korea’s next-generation flagship sector, experts call for integrated management led by the government.In an article published in the industrial brief of the Korea Health Industry Development Institute (KHIDI)
Lilly Korea's CDK4/6 inhibitor Verzenio (ingredient: abemaciclib) will be an alternative treatment for the complete recovery of early breast cancer patients with a high risk of recurrence, the company said Wednesday.In November, Lilly Korea obtained expanded indication approval from the Ministry of
The nation should check its healthcare system before it gets too late to effectively prepare for repeated disastrous infectious diseases, like new influenza, MERS, and Covid-19, experts pointed out Tuesday.At a joint forum co-hosted by three organizations, including the Korean Federation of Science